AEON Biopharma (AEON) Other Accumulated Expenses (2022 - 2026)

AEON Biopharma has reported Other Accumulated Expenses for 4 years, with the latest figure at $1.7 million in Q4 2025.

• Quarterly Other Accumulated Expenses fell 53.97% year-over-year to $1.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 million (down 53.97% YoY) and the FY2025 annual result came in at $1.7 million, down 53.97% from the prior year.
• Other Accumulated Expenses eased to $1.7 million in Q4 2025 per AEON's latest filing, from $2.6 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $4.1 million in Q1 2024 and troughed at $740000.0 in Q4 2022.
• A 4-year average of $2.9 million and a median of $3.0 million in 2025 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2023 and 2025: Other Accumulated Expenses jumped 385.14% in 2023, then sank 53.97% in 2025.
• Over 4 years, Other Accumulated Expenses stood at $740000.0 in 2022, then surged by 385.14% to $3.6 million in 2023, then increased by 0.28% to $3.6 million in 2024, then tumbled by 53.97% to $1.7 million in 2025.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $1.7 million, $2.6 million, and $3.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.